Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lauren B. Hall"'
Autor:
Caroline J. Rieser, Jurgis Alvikas, Heather Phelos, Lauren B. Hall, Amer H. Zureikat, Andrew Lee, Melanie Ongchin, Matthew P. Holtzman, James F. Pingpank, David L. Bartlett, M. Haroon A. Choudry
Publikováno v:
Annals of Surgical Oncology. 29:2630-2639
Autor:
Caroline J. Rieser, Richard S. Hoehn, Mazen Zenati, Lauren B. Hall, Eliza Kang, Amer H. Zureikat, Andrew Lee, Melanie Ongchin, Matthew P. Holtzman, James F. Pingpank, David L. Bartlett, M. Haroon A. Choudry
Publikováno v:
Annals of Surgical Oncology
Ann Surg Oncol
Ann Surg Oncol
Background Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS HIPEC) can offer significant survival advantage for select patients with colorectal peritoneal metastases (CRPM). Low socioeconomic status (SES) is implicated in di
Autor:
David L. Bartlett, James F. Pingpank, Matthew P. Holtzman, Reetesh K. Pai, Susan Shyu, Lauren B Hall, Haroon A. Choudry
Publikováno v:
Histopathology. 77:798-809
AIMS Peritoneal spread is the most common route of metastasis in appendiceal goblet cell adenocarcinoma. The aim of this study was to assess the prognostic significance of the World Health Organization (WHO) 5th edition grading criteria in peritoneal
Autor:
Andrew Lee, James F. Pingpank, Matthew P. Holtzman, Shannon Altpeter, Melanie Ongchin, Caroline J. Rieser, David L Bartlett, M. Haroon A. Choudry, Amer H. Zureikat, Lauren B Hall, Eliza Kang, Heather Jones
Publikováno v:
Ann Surg Oncol
INTRODUCTION: Early recurrence (ER) is a significant challenge for patients with colorectal peritoneal metastases (CRPM) following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS HIPEC). Preoperative risk stratification for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35eb5532ddc82a4bef8b9c86688e0e8
https://europepmc.org/articles/PMC8666126/
https://europepmc.org/articles/PMC8666126/
Autor:
Caroline J, Rieser, Jurgis, Alvikas, Heather, Phelos, Lauren B, Hall, Amer H, Zureikat, Andrew, Lee, Melanie, Ongchin, Matthew P, Holtzman, James F, Pingpank, David L, Bartlett, M Haroon A, Choudry
Publikováno v:
Annals of surgical oncology. 29(4)
Failure to thrive (FTT) is a complex syndrome of nutritional failure and functional decline. Readmission for FTT following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS HIPEC) is common but underexamined. This study aims to
Autor:
Caroline J. Rieser, Jurgis Alvikas, Heather Phelos, Lauren B. Hall, Amer H. Zureikat, Andrew Lee, Melanie Ongchin, Matthew P. Holtzman, James F. Pingpank, David L. Bartlett, M. Haroon A. Choudry
Publikováno v:
Annals of Surgical Oncology. 29:2640-2640
Autor:
Caroline J. Rieser, Amer H. Zureikat, James F. Pingpank, Matthew P. Holtzman, David L Bartlett, M. Haroon A. Choudry, Lauren B Hall, Eliza Kang
Publikováno v:
Annals of Surgical Oncology
Background Ninety-day hospital readmission rates following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) range from 20 to 40%. Objective The aim of this study was to develop and validate a simple score to predict rea
Autor:
Matthew P. Holtzman, Amer H. Zureikat, Melanie Ongchin, David L Bartlett, Caroline J. Rieser, James F. Pingpank, Andrew Lee, Mazen S. Zenati, M. Haroon A. Choudry, Richard S. Hoehn, Eliza Kang, Lauren B Hall
Publikováno v:
Annals of Surgical Oncology. 28:875-875
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS HIPEC) can offer significant survival advantage for select patients with colorectal peritoneal metastases (CRPM). Low socioeconomic status (SES) is implicated in disparities i